Given that in vivo lovastatin treatment is sufficient to inhibit tumor growth per se (Fig 4B and 4C), and promotes DR5 expression in vitro (Fig 1D), we next examined DR5 expression in subcutaneous brain tumor tissues collected from mice treated with lovastatin. This evidence concerns the gene TNFRSF10B and brain neoplasm.